Advertisement
Interrupting the Transmission of Soil-transmitted Helminths through Mass Drug Administration: The DeWorm3 trial protocol

January 18, 2018

Interrupting the Transmission of Soil-transmitted Helminths through Mass Drug Administration: The DeWorm3 trial protocol

Kristjana Hrönn Asbjornsdottir and colleagues offer a protocol to conduct a series of cluster randomized trials in Benin, India and Malawi to evaluate the impact of biannual community-wide mass drug administration (MDA) with albendazole compared to the current standard of care 

Image credit: SuSanA Secretariat, Flickr

PLOS Neglected Tropical Diseases: Ten Years of Serving the Global Community

Explore our 10th anniversary collection, blog, & journal retrospective and learn about upcoming events.

Click Here

Recently Published Articles

Current Issue

Current Issue December 2017

01/18/2018

research article

Mycobacterium bovis in Mozambique

Margarida Correia-Neves and colleagues combine genotyped M. bovis samples from cows across African countries to study the diversity and evolution of bovine tuberculosis and integrate the results in a new phylogenetic tree. Read the Author Summary

Image credit: Correia-Neves, et al. 2017

Mycobacterium bovis in Mozambique

01/12/2018

Research Article

Multi-drug resistant non-typhoidal Salmonella (NTS) associated with invasive disease

Adam Akullian and colleagues address which specific host and pathogen risk factors are associated with blood stream infection from NTS in rural Kenya, and find that multi-drug resistant (MDR) strains of NTS were associated with NTS bacteremia after controlling for know host-factors, suggesting that multi-drug resistant NTS is associated with blood stream infection even in the immune-competent host. Read the Author Summary

Image credit: CDC/ Bette Jensen, 2012

Multi-drug resistant non-typhoidal Salmonella (NTS) associated with invasive disease

01/12/2018

research article

Clinical trial methodologies for localized cutaneous leishmaniasis (CL)

Piero Olliaro and colleagues summarize the principles and parameters agreed upon by researchers of how to identify patients with CL and how to measure treatment effects in a way that will make it possible to gather convincing evidence of whether a treatment works or not. Adhering to these principles will allow faster progress towards offering better care to patients with this disease. Read the Author Summary

Clinical trial methodologies for localized cutaneous leishmaniasis (CL)

Image credit: Jean Fortunet, 2004

Get new content from PLOS Neglected Tropical Diseases in your inbox

Thank you! You have successfully subscribed to the PLOS Neglected Tropical Diseases newsletter.

Sorry, an error occurred while sending your subscription. Please try again later.

Try again